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1. Introduction 
Obstructive Sleep Apnea Syndrome (OSAS) is a common sleep-related breathing disorder 
affecting 5% of the general population (Young et al., 2002). OSAS is characterized by 
periodic complete or partial cessation of breathing while sleeping. These recurrent events of 
breathing result in fragmented sleep and recurrent hypoxemia (reductions in hemoglobin 
oxygen levels) (American Academy of Sleep Medicine, 1999). It has been documented that 
OSAS causes excessive daytime sleepiness, mood changes and dysfunctions in several 
cognitive domains (Engleman & Joffe, 1999; Tsara et al., 2009). However, there are different 
opinions on which cognitive abilities are affected mostly by OSAS and on the exact nature of 
cognitive decline. The comparison of the findings of research studies is difficult because of 
differences in severity of disease, criteria that are used to assess the severity of syndromes 
and different sample sizes (Quan et al., 2006). Other variables such as the sensitivity of 
neuropsychological battery chosen (Quan et al., 2006) and different group ages are also 
confounding factors (Mathieu et al., 2008). Nevertheless, in this chapter an effort is made to 
review studies which examined neurocognitive deficits in OSAS as well as those which 
reported the Continuous Positive Pressure Therapy (CPAP) treatment effects on several 
cognitive domains found to be impaired in OSAS. In addition, the most frequent 
explanations concerning the mechanism of neurocognitive deficits in OSAS patients and the 
neuroanatomical pathophysiology of OSAS are discussed.  
2. Obstructive sleep apnea – Hypopnea syndrome 
Obstructive sleep apnea is part of a spectrum of sleep related breathing disorders which also 
includes central sleep apnea (CSA) (apnea without respiratory effort, defined as 50% or 
more of respiratory events are central), mixed sleep apnea (episodes of obstructive sleep 
apnea and central sleep apnea), upper airway resistance syndrome (increased respiratory 
effort without apnea or hypopnea) and snoring (Avidan, 2005; Lim et al., 2007). Obstructive 
sleep apnea/hypopnea syndrome is defined as an obstruction of airflow for 10 seconds or 
longer. It occurs when the muscles relax during sleep, causing soft tissue in the back of the 
throat to collapse and block the upper airway. Apnea is characterized by the cessation of 
airflow (decrements in airflow of ≥90%) for 10 seconds or more (Avidan, 2005; Lim et al., 
2007; Qureshi & Ballard, 2003). On the other hand, hypopnea is usually characterized by a 
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reduction of ≥50% in airflow for 10 seconds associated with a ≥4% decrease in oxygen 
saturation and/or arousal (Tsai et al., 1999) while in accordance with the American 
Academy of Sleep Medicine guidelines hypopnea is defined as a decrease of ≥30% in airflow 
followed by ≥4% oxygen desaturation (Qureshi & Ballard, 2003).  
The diagnosis of the syndrome is based on daytime and nocturnal symptoms and especially 
on a full-night polysomnogram (Andreou et al., 2002), which includes 
electroencephalographic, electro-oculographic, electromyographic, oxygen saturation, oral 
and nasal airflow, respiratory effort, electrocardiographic and leg movement recordings 
(Qureshi & Ballard, 2003). OSAS severity is defined according to apnea-hypopnea index 
(AHI), by calculating the sum of apneas plus hypopneas per hour of sleep. According to 
apnea/hypopnea index (AHI), OSAS patients are divided into 3 groups of severity: mild 
OSAS (AHI≥5), moderate OSAS (AHI= 15-30), and severe OSAS (AHI≥30) (Qureshi & 
Ballard, 2003; Tsara et al., 2009). The occurrence of OSAS among children is 1-3 % (Beebe & 
Gozal, 2002). It affects 2% of women and 4% of men in middle age adults (Young et al., 
1993). In older adults (≥65 years), it has been reported that 62% of them present hypopnea 
episodes and 24% have apnea episodes above normative index (Ancoli – Israel et al., 1991). 
A newest study on a population – based sample of subjects aged 30 to 70 year found that 
19% of men and 15% of women have AHI≥ 10 (Durán et al., 2001). 
Obstructive sleep apnea syndrome is characterized by a perturbation of the pharyngeal 
dilator muscles associated with or without faulty upper airway anatomy such as 
macroglossia, hypertrophy of tonsils and long uvula (Avidan, 2005; Quereshi & Ballard, 
2003). Other risks factors that enhance the probability of OSAS are obesity, increased neck 
circumference, positive family history, male postmenopausal status, Down syndrome, 
Pierre-Robin syndrome, alcohol consumption before bedtime, tobacco and hypnotics use as 
well as sleeping in supine position (Qureshi & Ballard, 2003; Sánchez et al., 2009). These 
factors result in episodes of complete or partial upper airway obstruction during sleep and 
in increased sleep arousals that terminate the apneic episodes. These disturbing events 
while sleeping cause decreased oxygen saturation as well as sleep fragmentation (Avidan, 
2005, Beebe & Gozal, 2002; Quereshi & Ballard, 2003).  
In addition, it has been shown that sleep architecture changes in OSAS (Avidan, 2005; 
Sanchez et al., 2009). A normal sleep cycle consists of a cycling from non-REM sleep (non-
rapid eye movement), which consists of four stages (stage 1, stage 2, stage 3, stage 4), into 
REM sleep (rapid eye movement) with a periodicity that lasts for about 90 min. As the night 
goes on, stages 3 and 4 become shorter and REM sleep longer. On the other hand, in OSAS, 
it has been found that  stage 2 is increased and stage 1, stage 3, stage 4 and REM sleep 
decreased (Avidan, 2005; Sánchez et al., 2009), although there are different opinions on the 
decreased total time of REM sleep (Kiralti et al., 2010; Yaouhi et al., 2009). This abnormal 
sleep architecture makes sleep lighter and less restorative (Sánchez et al., 2009).  
The most well known symptom of obstructive sleep apnea/hypopnea syndrome is excessive 
daytime sleepiness (Lim et al., 2007; Ferini-Strambi, 2003), although some studies failed to 
report daytime somnolence (Barbé et al., 2001; Black, 2003). Daytime sleepiness is usually 
assessed with Epworth Sleepiness Scale (ESS) (Tsara et al., 2009) and the majority of patients 
with OSAS report that they fall asleep in quiet and monotonous situations such as watching 
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television, reading a book, or driving a vehicle (Sánchez et al., 2009). Fatigue, non - 
refreshing sleep, insomnia, loud snoring, gasping, choking, and reports of breathing 
interruptions by bed partner are common daytime and nocturnal symptoms of sleep apnea 
(Saunamäki & Jehkonen, 2007). Poor quality of life, poor interpersonal relationships, low 
work and school efficiency have been observed in OSAS patients (Engleman & Joffe, 1999; 
Kales et al., 1985). Moreover, patients with OSAS have a high frequency of psychopathology 
such as depression and hypochondriasis (Kales et al., 1985; Muñoz et al., 2000). In addition, 
patients with OSAS present increased morbidity due to high rates of cardiovascular diseases 
and hypertension (Kales et al., 1985; Lattimore et al., 2003) as well as increased mortality 
(Engleman & Joffe, 1999; Kales et al., 1985). 
The treatment of OSAS is based on restoring the upper airway flow. For that reason, the 
most effective treatment for patients with craniofacial abnormalities is surgical treatment. In 
the rest of OSAS patients the most effective treatment is the Continuous Positive Pressure 
Therapy (CPAP) which consists of an air pressure generating device and a fitting mask that 
is applied over the nose or the mouth of the patient. The positive air pressure maintains 
upper airway patency and prevents upper airway obstruction while the patients are asleep 
(Avidan, 2005; Qureshi & Ballard, 2003). CPAP therapy has been shown to improve 
nocturnal breathing, oxygen saturation (Avidan, 2005), and mean blood pressure 
(Jaimchariyatam et al., 2010). As a result, it decreases hypertension and the risk of 
cardiovascular and cerebrovascular events (Lattimore et al., 2003). CPAP therapy also 
decreases daytime sleepiness (Muňoz et al., 2000) and improves OSAS patients’ mood 
(Engleman et al., 1994) and quality of life (Engleman et al., 1999). However, these positive 
effects have not been always reported (Barbé et al., 2001).  
3. Neurocognitive deficits in obstructive sleep apnea syndrome 
Patients with OSAS show deficits across a wide range of cognitive functions including 
attention, memory, psychomotor speed and visuospatial abilities, constructional abilities, 
executive functions and language abilities (Andreou & Agapitou, 2007; Engleman & Joffe, 
1999; Findley et al., 1986).  
3.1 Attention 
Patients with obstructive sleep apnea syndrome have been found to show a decline in 
vigilance (Aloia et al., 2004; Beebe et al., 2003; Décary et al., 2000; Rouleau et al., 2002) and in 
complex attention (Lau et al., 2010), such as sustained attention (Kotterba et al., 1998), and 
selective attention (Kotterba et al., 1998). More specifically, research has shown that severe 
OSAS patients are characterized by diffused impairments in vigilance (Findley et al., 1986; 
Lim et al., 2007; Muñoz et al., 2000,) and in sustaining attention and alertness (Findley et al., 
1986; Lim et al., 2007). It has been shown that a group of OSAS patients of similar severity of 
disease, displayed poor performance in Stroop Color, TR2 (Reaction Time Test) (Ferini-
Strambi et al., 2003), digit symbol and Steer Clear test (Kingshott et al., 2000), tests which 
assess selective attention, sustained attention and vigilance. The study of Mathieu et al. 
(2008) is consistent with these results and shows that a group of 28 patients with severe 
OSAS and mild hypoxemia, compared to 30 controls, gave low scores in sustaining attention 
and vigilance measured with four-choice reaction time test.  
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Moderate and severe OSAS patients have been found to show diffused impairment in 
vigilance assessed with the Steer-Clear test (Engleman et al., 1994). Moreover, a large 
majority of moderate and severe sleep apnea patients demonstrated attention deficits on 
vigilance, selective, sustained and divided attention (Mazza et al., 2005). On the other hand, 
there have been studies on moderate and severe OSAS patients that failed to report deficits 
in attention measured with digit symbol test (Pierobon et al., 2008), digit span, and letter-
sequence subtasks of Wechsler test (Yaouhi et al., 2009).  
Moderate OSAS patients performed normally in digit symbol, digit forward subtest of 
WAIS, Paced Auditory Serial Addition Test (PASAT), and Steer clear tests that assess 
sustained, divided attention and vigilance (Monasterio et al., 2001). Twigg et al. (2010) did 
not observe significant attention deficit assessed with Stroop Color test, digit span forward 
and Trail Making Test A (TMT A) in mild-to-severe OSAS patients. Mild and moderate 
OSAS patients, compared to a healthy control group, did not present any significant 
impairments in attention either (Quan et al., 2006). Finally, there has not been observed any 
poor performance on Steer Clear test and Trail Making test A in patients with mild OSAS 
(Engleman et al., 1999). In conclusion, there is not any significant attention decline in non - 
homogenous groups of patients and only severe OSAS patients present poor performance in 
attention tasks.  
3.2 Psychomotor speed 
Several studies (Décary et al., 2000; Lau et al., 2010; Rouleau et al., 2002) have noted 
decrements in psychomotor efficiency, which appeared to be the most consistent 
explanation for characterizing the profile of neuropsychological test results among OSAS 
patients. Lim et al. (2007) compared normative data to severe OSAS patients’ performance in 
psychomotor tasks and found a decline in psychomotor speed measured with Digit symbol, 
Digit vigilance, Trail Making Test A and Stroop color test. However, differences among 
severe OSAS patients and healthy controls in Trail making test performance have not been 
always detected (Mathieu et al., 2008). There has been some evidence for psychomotor 
speed deficit in moderate and severe OSAS patients (Felver - Gant et al., 2007). Yaouhi et al. 
(2009) also observed a decreased performance in Purdue Pegboard test in a similar group of 
patients compared to healthy controls. In a recent study, Twigg et al., (2010) did not observe 
any psychomotor deficits in mild-to-severe OSAS patients measured with TMT. Finally, 
patients with mild and moderate OSAS compared to controls did not show any significant 
poor performances on Grooved Pegboard test (GPT), digit symbol or digit search tasks 
(Quan et al., 2006). Therefore, it is concluded that attention decline prevalence is higher in 
severe OSAS patients than in moderate or mild OSAS patients.  
3.3 Memory and learning 
There is a significant number of studies which have shown a serious decline in memory and 
learning abilities in OSAS patients (Décary et al., 2000), such as episodic memory (Daurat et 
al., 2008), short-term memory (Borak et al., 1996; Findley et al., 1986; Naëgelé et al., 1998), 
long-term verbal memory (Aloia et al., 2003) and verbal and visual learning abilities 
(Feuerstein et al., 1997). In contrast to studies that did not show any immediate memory 
decline in severe OSAS patients (Grenèche et al., 2011; Mathieu et al., 2008), other studies 
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found that OSAS patients’ performance was poor in short-term verbal memory tests such as 
digit span test and word list recall (Borak et al., 1996; Lee et al., 2009). The study of Lim et al. 
(2007) compared normative data to severe OSAS patients’ performance on Hopkins Verbal 
Learning Test (HVLT) and showed a diffused impairment in verbal short and long-term 
learning and memory. Another study showed that 50% of their OSAS patients presented 
poor performance in Wechsler memory scale, whereas only 9% of their patients had 
difficulties in both short and long-term memory (Kales et al., 1985). However, a short-term 
and long-term verbal memory decline was not always found in severe OSAS patients with 
an average AHI of 54,95 per hour (Ferini-Strambi et al., 2003). Patients with severe OSAS 
compared with healthy controls, preserved a good short-term memory and long-term 
episodic memory measured with digit span forward, immediate recall of Rey Auditory 
Verbal Learning Test (RAVLT), Digit span backward and delayed recall of RAVLT task. 
Procedural memory measured with Mirror tracing test was also found intact. Only the 
performance in immediate recall and the learning of story B of Wechsler memory scale was 
found decreased (Mathieu et al., 2008).  
Regarding working memory, some studies did not find a significant decline in patients with 
severe OSAS (Ferini-Strambi et al., 2003; Mathieu et al., 2008), whereas other studies did 
(Grenèche et al., 2011). Severe OSAS patients’ also present visual (Borak et al., 1996; Lee et 
al., 2009; Ferini - Strambi et al., 2003) and spatial memory decline (Borak et al., 1996). 
Moderate and severe OSAS patients have been presented with poor verbal immediate and 
delayed recall measured with HVLT (Felver – Gant et al., 2007) RAVLT and Logical Memory 
Test (Findley et al., 1986; Torreli et al, 2011). However, no significant deficits in episodic 
memory, measured with verbal logical memory and visual memory of Wechsler test have 
been observed by Yaouhi et al. (2009). Interestingly, only paired associates – learning curve 
and percent of retained items in family pictures was impaired (Yaouhi et al., 2009). Pierobon 
et al. (2008) found significantly lower scores on short-term memory (digit span), and on 
spatial short-term memory tests (Corsi block test) in their OSAS patients sample in contrast 
to long-term verbal memory (prose memory test) which was intact. Working memory 
problems have also been found in moderate and severe OSAS patients assessed with 2-back 
working memory test, Paced Auditory Serial Addition Test (PASAT) (Felver –Gant et al., 
2007) and digit span backward (Torreli et al., 2011). In contrast to this, Yaouhi et al. (2009) 
did not find any working memory problems in a group of patients of similar severity. No 
differences between normal and mild-to-severe patients in visual memory and verbal 
working memory have been found by Twigg et al. (2010). Only immediate and delayed 
recall of logical memory test as well as spatial working memory were impaired (Twigg et al., 
2010). Finally, patients with moderate OSAS did not show any decline in visual or verbal 
memory assessed with Wechsler Memory Scale (WMS) (Monasterio et al., 2001). Therefore, 
it seems that memory decline is equivocal in non severe patients and in groups of patients 
that were not homogenous in OSAS severity.  
3.4 Visuospatial and motor constructional abilities 
Patients with severe OSAS have been found to have poor visuospatial and constructional 
abilities measured with tests such as Rey-Ostrerrieth and Purdue Pegboard (Ferini - Strambi 
et al., 2003). Aloia et al. (2003) also found poor constructional abilities in severe OSAS 
patients measured with visual motor integration (VMI) test. Moderate and severe OSAS 
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patients scored lower on Rey-Ostrerrieth copy task in comparison to copy drawings and 
Rey-Ostrerrieth figure recall (Torelli et al., 2011).  
3.5 Executive abilities 
The majority of the studies have found executive dysfunctions related to mental flexibility, 
planning, working memory, analysis, synthesis and organizational skills in OSAS patients 
(Lau et al., 2010; Saunamäki & Jehkonen, 2007). Low scores in tests such as TMT, block 
design, Intra-Extra Dimensional Set Shifting test (Meurice et al., 1996; Saunamäki et al., 
2009), verbal fluency (Andreou & Agapitou, 2007), digit symbol and copying the Rey - 
Osterrieth complex figure have been observed in many studies (Feuerstein et al., 1997; 
Naëgelé et al., 1998). Executive dysfunctions, measured with Raven matrices, Digit symbol, 
phonemic task of verbal fluency, Letter-number sequencing, Stroop Color-Word test and 
TMT B, have been observed in patients with severe OSAS (Aloia et al., 2003; Bardwell et al., 
2001; Lim et al., 2007; Ferini - Strambi et al., 2003). On the other hand, Mathieu et al. (2008) 
failed to find several noteworthy low scores in trail making B and Wisconsin test. 
Regarding moderate and severe OSAS patients, it has been found that they performed 
poorly in Trail making test B (Engleman et al., 1994; Felver - Gant et al., 2007) in Stroop test 
and Digit span (Torelli et al., 2011). On the other hand, there are studies on moderate and 
severe OSAS patients that did not report any impairment in executive functions assessed 
with TMT (Pierobon et al., 2008), the phonological task of verbal fluency and Raven matrices 
(Torelli et al., 2011; Yaouhi et al., 2009).  
Mild-to-severe OSAS patients have been documented to have significant impairments in 
mental shift, planning and working memory measured with Stroop test, Raven matrices, 
digit span backward and trail making test, and had a minimal decline in phonemic fluency 
(Twigg et al., 2010). In mild and moderate OSAS patients, Quan et al. (2006) found that 
executive functions, as measured with Stroop test and Trail making B, were affected a little. 
In addition, moderate OSAS patients were found to perform among the typical range in 
digit symbol, block design, PASAT and verbal fluency test (Engleman et al., 1999; 
Monasterio et al., 2001). Regarding patients’ performance on TMT, Monasterio et al. (2001) 
observed a significant decline in contrast to the findings of Engleman et al. (1999) who did 
not demonstrate this decline.  
It is remarkable that some researchers have found that patients’ performance on TMT B 
(Naëgelé et al., 1998; Ferini –Strambi et al., 2003), Wisconsin card sorting test (Salorio et 
al., 2002) and letter verbal fluency (Naëgelé et al., 1998; Torelli et al., 2011) are normal 
although their performance was poor in the rest of neuropsychological tests that are 
sensitive to the detection of executive dysfunctions. One possible explanation is that there 
is a pattern of both intact and impaired cognitive functions in OSAS patients that make 
the executive impairments difficult to detect (Lis et al., 2008). More specifically, Grenèche 
et al. (2011) proposed that there is a specific working memory deficit associated with 
complex memory tasks and high level memory scanning. Additionally, it has been 
suggested that deficits in tasks that require high executive functions are apparent only 
over the course of the day due to circadian variations or duration of time spent awake (Lis 
et al., 2008). 
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3.6 Language functions 
Most studies on OSAS patients focus more on cognitive functions such as attention, 
memory and executive functioning rather than on language abilities. Probably, this is 
associated with the fact that attention and memory problems are more easily noticed by 
patients, their bed partners and doctors, than language deficits. It has been reported that 
62% of OSAS patients show speech disorders, which correlate with sleep deprivation and 
its effects on neuromotor function (Monoson & Fox, 1987). Furthermore, there have been 
reports on OSAS patients that have shown significant semantic language deficits 
(Andreou & Agapitou, 2007; Feuerstein et al., 1997; Lee et al., 2009), although this has not 
always been found (Beebe et al., 2003). More specifically, Lim et al. (2007) compared 
normative data to severe OSAS patients’ performance in a verbal fluency test and found a 
significant impairment in semantic language in 30,4 % of this patient group. Other 
researchers also noted low scores in verbal fluency tests (Aloia et al., 2003; Bardwell et al. 
2001). On the other hand, Ferini - Strambi et al. (2003) have failed to show any significant 
decline in language abilities concerning semantic verbal fluency in OSAS patients while 
on the other hand their phonemic verbal fluency was found to be impaired (Ferini - 
Strambi et al., 2003).  
Moderate and severe OSAS patients have been found to show similar performance on 
semantic word fluency compared to healthy controls (Torelli et al., 2011). Minimal 
differences between mild -to- severe OSAS patients and healthy volunteers on semantic and 
phonemic verbal fluency are documented by Twigg et al. (2010). Moderate OSAS patients’ 
verbal fluency was also found to be within normal range by Monasterio et al. (2001). An 
interesting finding is that mild and moderate OSAS adolescents have shown significantly 
lower scores on semantic and phonemic tasks of verbal fluency. It is suggested that OSAS 
occurrence during critical ages of brain growth and development such as childhood and 
adolescence may cause notable language decline (Andreou & Agapitou, 2007).  
4. Neurocognitive improvement on OSAS patients after CPAP treatment  
Recent studies have shown that CPAP treatment is related to specific cognitive 
improvements (Avidan, 2005; Naëgelé et al., 1998). Sánchez et al. (2009), in a clinical review, 
have concluded that CPAP is effective in reducing symptoms of sleepiness, and improves 
some cognitive functions. Studying cognitive improvement after CPAP therapy is essential 
to draw safe results about the permanent cognitive dysfunctions owing to OSAS effects.  
4.1 Attention 
It has been found that a 1-week CPAP treatment improved attentional ability, although the 
effect was not significantly beneficial for the patients (Bardwell et al., 2001). Studies that 
have determined the effects of a 2-week CPAP treatment on severe OSAS patients found a 
significant improvement in vigilance, alertness and sustained attention (Ferini – Strambi et 
al., 2003; Lim et al., 2007). Research studies that assessed attention after 4 weeks of CPAP 
treatment also confirmed this improvement in vigilance and attention (Aloia et al., 2001; 
Engleman et al., 1994). Engleman et al. (1999) found that a 4-week CPAP treatment had a 
significant positive impact on attentional abilities measured with PASAT test and digit 
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symbol test. However, this group of patients with mild OSAS did not show a significant 
improvement on Steer Clear test. Patients using CPAP for more than 12 weeks showed an 
even greater improvement in vigilance than patients who were on a 4-week CPAP treatment 
(Aloia et al., 2001). Another study that evaluated the effects of 3-month CPAP treatment on 
severe OSAS patients, found an improvement in vigilance and sustained attention 
performances, assessed with Conner’s continuous performance test (Aloia et al., 2003). 
Studies that evaluated alertness, vigilance and sustained attention after 6 and 12 months 
CPAP treatment also found a significant decrease in these cognitive dysfunctions 
(Kingshott, et al., 2000; Kotterba et al., 1998; Muñoz et al., 2000).  
On the other hand, Engleman et al. (1998), in a small sample of 23 OSAS patients who were 
on a 4-week CPAP treatment, did not observe any improvement in attention measured with 
PASAT test, SteerClear test, TMT and digit symbol test. Barbé et al. (2001) found that a 6- 
week CPAP treatment in 55 non sleepy patients with severe OSAS did not modify the 
patients’ performance in vigilance and attention, measured with PASAT, TMT and digit 
symbols. Pelletier-Fleury et al. (2004) also failed to find any significant improvement in 
attention measured with TMT in patients who were on a 6-month CPAP treatment. 
However, in this study, OSAS patients were not equaled in terms of age. 
4.2 Psychomotor speed 
Bardwell et al. (2001) showed that a 1-week CPAP treatment did not improve very severe 
OSAS patients’ performance in Stroop Test and TMT. On the other hand, Lim et al. (2007) 
have shown that a 2-week CPAP treatment can significantly decrease the time to complete 
tests that measure psychomotor speed, such as digit vigilance, Stroop test and Trail Making 
Test A in severe OSAS patients. Studies on the effects of 3- and 6-month CPAP therapy on 
cognitive functions of severe OSAS patients observed a decrease in motor speed functions 
assessed with Purdue Pegboard test (Aloia et al., 2003) and in reaction time measured with 
TMT, PASAT test (Hoy et al., 1999) and digit symbol test (Kingshott et al., 2000). However, 
psychomotor speed improvement was not always found in moderate and severe OSAS 
patients (Felver - Gant et al., 2007) and non sleepy patients (Barbé et al., 2001). In another 
study, Engleman et al. (1998) did not find psychomotor speed improvement on severe OSAS 
patients after 4 weeks CPAP treatment. Finally, another study assessing the long-term 
effects of CPAP, (Muñoz et al., 2000) found that a 1-year CPAP therapy changed only a little 
OSAS patients’ reaction time measured with Psychometer vigilance test. 
4.3 Memory and learning 
Short-term CPAP treatment for 1 or 2 weeks did not notably improve severe OSAS patients’ 
short- after and long–term verbal memory, visuospatial and working memory, as well as 
learning ability measured with Hopkins verbal learning test, digit span and Brief 
visuospatial memory test  (Bardwell et al., 2001; Lim et al., 2007). On the other hand, Ferini - 
Strambi et al. (2003), found that 2-weeks and 4-months CPAP therapy had a significant 
positive impact on visuospatial learning tasks on 23 severe OSAS patients. According to 
other studies, a 3-month CPAP treatment had a positive effect on non-verbal recall task 
(Aloia et al., 2003) and working memory task (Felver - Gant et al., 2007). Borak et al. (1996) 
found that 20 severe OSAS patients who were on a 3-month CPAP treatment had a 
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significant improvement in recent verbal, visual and spatial memory. In addition, an over 
12-month CPAP therapy resulted in considerable improvement on verbal, visual and spatial 
memory in severe OSAS patients (Borak et al., 1996).  
On the other hand, a 1.5-months of CPAP treatment did not modify memory functions of 
non sleepy patients with severe OSAS (Barbé et al., 2001). Short-term memory impairment 
was also persistent in OSAS patients despite 4 and 6 months CPAP treatment (Feuerstein et 
al., 1997; Naëgelé et al., 1998) in contrast to learning disabilities and long-term memory 
decline (Feuerstein et al., 1997) which improved.  
4.4 Visuospatial and motor constructional abilities 
It has been observed that severe OSAS patients’ performance in assembly trail of Purdue 
Pegboard test improved significantly after 2-weeks (Ferini – Strambi et al., 2003), 3-months 
(Aloia et al., 2003) and 4-months CPAP treatment (Ferini – Strambi et al., 2003). However, no 
significant improvement in tasks that require high mental processes such as visual motor 
integration (VMI) was observed (Aloia et al., 2003). No significant improvement has been 
found in Rey – Osterrieth complex figure after 4-months (Ferini – Strambi et al., 2003) and 6 
months CPAP therapy (Saunamäki et al., 2009). The above findings led Aloia et al. (2004) to 
conclude that CPAP treatment failed to improve patients’ performance in constructional 
tasks.  
4.5 Executive abilities 
Short-term CPAP treatment for 1 and 2 weeks did not improve significantly patients’ 
performance in Stroop Color – Word test, TMT B and Letter – number sequencing (Bardwell 
et al., 2001; Lim et al, 2007). However, 3-week and 4-week CPAP treatment has been shown 
to improve mental flexibility measured with TMT (Engleman et al., 1994; Meurice et al., 
1996). Engleman et al. (1999) observed that patients’performance in digit symbol and 
PASAT test was improved, in contrast to TMT and blocks design performance (Engleman et 
al., 1999). Longer CPAP therapy (3-months) has been found to reverse the impairment in 
executive functions, since patients improved their performance in Verbal fluency test – 
Phonemic task and Trail making test B (Aloia et al., 2003), in contrast to another research 
study which did not find this improvement (Felver-Gant et al., 2007). Longer CPAP 
treatment for 4 or 6 months has also been found to improve executive functions, such as 
planning capacities and working memory (Feuerstein et al., 1997; Naëgelé et al., 1998; 
Saunamäki et al., 2009). Yet, patients with 6 months CPAP treatment did not completely 
reverse executive dysfunctions measured using Rey - Osterrieth complex figure test 
(Saunamäki et al., 2009). It seems that high order executive functions or specific domains of 
executive functions do not improve after CPAP treatment.  
4.6 Language functions 
There are a few research studies that explored the effects of CPAP treatment on language 
functions. 1- to 2-week treatment with CPAP failed to improve significantly patients’ 
performance in verbal fluency tasks (Bardwell et al., 2001; Lim et al, 2007) and in Boston 
naming test (Aloia et al., 2003). A study on severe OSAS patients found that their semantic 
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verbal fluency performance improved after a 15-day CPAP treatment although there was 
not a statistically significant difference between the healthy subjects’ performance and that 
of OSAS patients before the treatment (Ferini – Strambi et al., 2003).  
In conclusion, cognitive deficits in OSAS patients are partially reversible if treated with 
CPAP. More specifically, CPAP seems to improve only some aspects of cognitive functions. 
Neurocognitive deficits in high executive functions and verbal fluency do not seem to 
improve after CPAP treatment (Ferini – Strambi et al., 2003; Montplaisir et al., 1992). It is 
possible that hypoxemia may have caused permanent brain injury. On the other hand, 
cognitive tasks such as attention, psychomotor speed and memory that require low mental 
activation seem to improve after CPAP treatment. It is suggested that the improvement of 
these cognitive functions are due to improvement of daytime sleepiness and quality of sleep. 
The diversity in research results reflects differences in methodology, treatment duration, 
low tolerance of treatment, severity of OSAS, insufficiently sensitive neuropsychological 
measures and variability of the sample (Sánchez et al., 2009). 
5. Mechanism of cognitive impairment in OSAS patients 
The cause of cognitive deficits in OSAS patients is complicated. Some researchers have 
shown a significant correlation between cognitive impairment and daytime sleepiness 
related to sleep fragmentation resulting from frequent apneas (Valencia-Flores et al., 1996; 
Verstraeten, 2007) while others attribute cognitive decline to nocturnal hypoxemia (Berry et 
al., 1986; Findley et al., 1986). Finally, some researchers attribute cognitive impairments to a 
combination of PSG parameters (AHI, sleep arousals, oxygen desaturation, sleep 
architecture) (Cheshire et al., 1992; Quan et al., 2006). 
More specifically, Verstraeten et al. (2004) proposed that low order deficits such as 
attentional decline and slow mental processing underlie the more complex deficits found in 
executive functions. In this study, attention, vigilance and executive functions were assessed 
with TMT A, B, Stroop color –Word test and Symbol digit Modalities. The cognitive decline 
was comparable to the decline found after sleep loss. It has been concluded that sleep 
disruption has a pervasive influence on cognitive functions and affects not only underlying 
lower level processes such as arousal and alertness, but also higher – level cognitive 
processes such as executive functioning. In other words, high order cognitive dysfunction 
can be explained by impairment in both attentional decline and psychomotor speed 
decrements due to sleepiness (Verstraeten & Raymond, 2004). However, a discussion of 
sleep fragmentation and hypoxemia is limited in this model.  
Another explanation for the cognitive deficits found in OSAS patients suggested that 
attentional deficits and memory impairments are affected by sleep fragmentation while 
impairments in executive functions, in constructional abilities, in motor tasks and in 
language are caused by hypoxemia (Bérard et al., 1991; Kotterba et al., 1998; Naëgelé et al., 
1995). More specifically, attention decline was linked to vigilance impairment that derives 
from changes in sleep architecture (Bédard et al., 1991; Montplaisir et al., 1992). Ferini-
Strambi et al. (2003) also found that sustained attention was correlated with daytime 
sleepiness. Regarding the relation between psychomotor speed and hypoxemia, a significant 
interrelation was found (Bédard et al., 1991; Findley et al., 1986; Kotterba et al., 1998; 
Grenéche et al., 2011). Quan et al. (2006) observed this interrelation in mild and moderate 
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OSAS patients. More severe oxygen desaturation was associated with poorer motor 
performance and lower processing speed whereas stage 1 sleep, sleep arousals and daytime 
sleepiness were not correlated with these deficits (Quan et al., 2006). Regarding memory 
dysfunctions, it has been found that vigilance impairment due to sleep changes contribute to 
memory decline (Bérard et al., 1991; Montplaisir et al., 1992). Recently, studies on sleep 
architecture (percentage of slow wave sleep and rapid eye movements sleep) have shown 
that sleep architecture is negatively associated with immediate memory (forward digit span) 
and low level memory scanning (simple Sternberg) (Grenéche et al., 2011). In addition, 
Daurat et al. (2008) showed that the best predictor of episodic memory deficit was the 
number of microarousals. Constructional abilities have been found to positively associate 
with the time that oxygen saturation levels are below 80% (Aloia et al., 2003). Executive 
dysfunctions and hypoxemia seem to be interrelated (Findley et al., 1986; Montplaisir et al., 
1992). Ferini-Strambi et al. (2003) showed a significant correlation between the time of 
oxygen saturation (SaO2) below 90% or lowest peaks of SaO2 and the phonemic fluency or 
the Rey figure in severe OSAS patients. It has been reported that working memory and 
high-speed memory scanning deficits, factors pertaining to executive functions, are 
associated with the degree of hypoxemia (mean SaO2) (Aloia et al., 2003; Grenéche et al., 
2011). Regarding verbal disabilities, it has been found that hypoxia could predict patients’ 
performance on verbal fluency test (Berry et al., 1986). 
However, this explanation of cognitive deficits needs further elucidation as there are studies 
that failed to associate memory functions with sleep arousals, sleep architecture (Findley et 
al., 1986), daytime sleepiness (Lojander et al., 1999) or severity of disease (Lojander et al., 
1999; Twigg et al., 2010). Some other studies found a link between hypoxia and attention 
(Kotterba et al., 1998), verbal and non-verbal memory (Berry et al., 1986; Findley et al., 1986) 
as well as delayed recall (Aloia et al., 2003). On the other hand, the total time of SWS and 
REM amount were associated with language and executive functions respectively (Lee et al., 
2009). Moreover, there is a research study which failed to associate executive functions, such 
as working memory, with hypoxia (Felver-Gant et al., 2007). Some other studies found that a 
specific cognitive decline such as verbal delayed memory impairment is associated with 
both sleep fragmentation and oxygen desaturation (Aloia et al., 2003; Kiralti et al., 2010).  
Beebe and Gozal (2002) have suggested that the frontal lobes of the brain are affected by 
sleep fragmentation and hypoxemia. Sleep fragmentation is proposed to affect frontal lobes 
by disrupting the normal restorative processes of sleep, while hypoxemia causes cellular 
changes in the prefrontal cortex. A recent study on a small group of severe OSAS patients 
suggested that both hypoxia and sleep fragmentation contribute to frontal dysfunction (Xi et 
al., 2011). However, this explanation model of cognitive deficits includes exclusion of brain 
regions other than frontal lobe and little discussion of the nuances of executive functions. 
Moreover, there are studies that do not ascribe cognitive dysfunctions to both hypoxia and 
sleep deprivation, i.e., in tasks that assess verbal short-term and long-term memory, non 
verbal memory, constructional abilities, language (Mathieu et al., 2008; Pierobon et al., 2008; 
Torelli et al., 2011), attention and executive functions (Lis et al., 2008; Mathieu et al., 2008; 
Mazza et al., 2005). 
Another model, the microvascular theory, has been proposed by Aloia et al (2004). This 
model suggests that a vascular compromise might exist in the small vessels of the brain and 
the intermittent hypoxemia of OSAS may affect the regions of the brain that are 
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metabolically active during hypoxemia. Microvascular disease of small vessels that feed 
white matter of the brain may result in deficits of attention, mental processing, memory 
executive functions, motor speed and coordination. Recent studies have shown that 
hypercapnia, cortical and sympathetic activation in OSAS patients cause cardiovascular, 
cerebrovascular and metabolic disease as well as sudden death (Lloberes et al., 2011). More 
specifically, repetitive episodes of deoxygenation and reoxygenation increase the 
production of proinflammatory cytokines (TNF), C-reactive protein and chemoreceptors 
that are associated with the development of atherosclerosis and high arterial pressure 
(Lloberes et al., 2011). However, hypoxia, hypercapnia, sleep fragmentation, hemoglobin 
levels, inflammation parameters and comorbidities are unlikely to account for all cognitive 
dysfunctions (Dodd et al., 2010).  
Beebe (2005) proposed that multiple factors affect the neurocognitive functions in OSAS. It 
has been suggested that sleep fragmentation and hypoxemia effects are intermingled and 
synergistic. He proposed that these synergistic mechanisms interact with vulnerable brain 
regions such as hippocampus, prefrontal cortex, subcortical gray and white matter, 
suggesting the potential involvement of small vessels in the brain. Regarding the complexity 
of higher order cognitive abilities such as executive functions, Beebe (2005) suggested that 
these higher order functions may be dependent on task demands, or the environment of 
testing, while some specific deficits may be related to some tasks but not others. Other 
factors such as sociodemographic factors, previous experience on testing and genetic 
endowment, may also affect cognitive performance (Beebe, 2005). Moreover, Mathieu et al. 
(2008) found that younger OSAS patients are more sensitive than older OSAS patients to 
sleep defragmentation and hypoxia. Another study found that socioeconomic status and 
adolescent cognitive ability may explain verbal disability, verbal memory decline, or rate of 
impairment in memory (Richards et al., 2005). Finally, Alchanatis et al. (2005) have proposed 
that intelligence and cognitive functions are interrelated. In other words, high – intelligence 
may have a protective effect against cognitive decline in OSAS patients, due to increased 
cognitive reserve.  
6. Neuroanatomical pathophysiology of OSAS 
In obstructive sleep apnea syndrome, compared to other sleep disorders, at least two 
primary nocturnal abnormalities occur: hypoxemia and sleep fragmentation. It has been 
found that a decreased oxygen transport to brain cells modifies ion channels (potassium, 
sodium, calcium) and as a result cell excitability increases. In addition, it causes alterations 
in neurotransmitters (dopamine, acetylcholine, ATP), and reduces respiration followed by 
enhancement of sympathetic and respiratory activities which result in changes involving 
modification in signaling pathways, in neuromodulators and their receptors as well as 
genome effects (Areza-Fegyveres et al., 2010; Powell, 2007). It has also been found that 
frequent oxygen desaturation during everyday activity elevates choline level in frontal brain 
areas and high levels of choline damage myelin and membrane precursors (Gibson et al., 
1981). Hypoxia is also associated with enhancement of hemoglobin concentration level, 
which can affect cognitive abilities (Grant et al., 1982). Moreover, it may increase hematocrit 
level and angiogenesis through enhancement of production of vascular growth factors 
(Areza-Fegyveres et al., 2010). Finally, it is believed that hypoxia, inflammation and 
oxidative stress initiate the process of endothelian dysfunction that plays a significant role in 
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vascular tone and cellular growth (Butt et al., 2010). Some regions of the brain, such as the 
hippocampus, basal ganglia, cerebellum, occipital cortex and frontal regions are more 
susceptible to oxygen deprivation than others (Martin et al., 2011). More specifically, 
functional magnetic resonance image (fMRI) studies revealed a significant gray matter loss 
and atrophy in several brain regions including cortex, hippocampus and striatum 
suggesting that chronic exposure to hypoxia results in neuronal damage and impaired 
cognitive functions (Maiti et al., 2008; Shukitt-Hale et al., 1996).  
Regarding sleep loss effects on brain, it has been found that it decreases pineal melatonin 
production which causes disturbances in circadian physiology of cells, organs, 
neurochemicals, neuroprotective and other metabolic functions (Jan et al., 2010). Moreover, 
it have been found that short-term and long-term sleep deprivation has both been associated 
with the upregulation of hundreds of genes in the cerebral cortex and other brain areas. This 
includes genes that are associated with energy metabolism, memory formation, memory 
consolidation, protein synthesis and synaptic depression (Cirelli et al., 2006). It is well 
established that chronic sleep deprivation or sleep fragmentation in healthy subjects may 
cause decline in alertness, simple attention, psychomotor speed as well as learning, memory, 
working memory and executive functions (Killgore, 2010; Whitney & Hinson, 2010; 
Reynolds & Banks, 2010). A functional magnetic resonance imaging (fMRI) study has shown 
the negative impact of sleep deprivation on specific brain regions, such as temporal to 
parietal regions and frontal lobe regions (Jan et al., 2010). In addition, it has been suggested 
that long-term sleep deprivation may cause permanent neuronal alterations especially in 
memory related brain regions, such as hippocampus (Jan et al., 2010). Killgore (2010) 
observed that chronic sleep deprivation is followed by reduced activation of frontal and 
parietal networks and alters functioning within the thalamus.  
Regarding the neuropathophysiology of OSAS, patients are presented with blood flow 
reduction during apneic episodes in left frontal and temporal lobes (Kiralti et al., 2010). 
Yaouhi et al. (2009) found a right-lateralized decreased brain metabolism in precuneus, 
middle and posterior cingulated gyrus, and the parieto – occipital cortex, as well as the 
prefrontal cortex (Yaouhi et al., 2009). Joo et al. (2007) also found reduced cerebral blood 
flow during wakefulness in bilateral hippocampal gyri, right lingual gyrus, precentral 
gyrus, and cuneus in patients with severe OSAS. These findings may partly explain the 
deficit in memory, spatial learning, executive function, and attention which are frequently 
found in OSAS patients (Joo et al., 2007). Xi et al. (2011), using fMRI, observed that OSAS 
patients showed a decreased mismatch-related activation in frontal regions such as 
prefrontal cortex and anterior cingulate, whereas an increased activation was only found in 
the right anterior prefrontal gyrus. Another study (Joo et al., 2009) which used fMRI to 
assess gray matter volume in OSAS patients, has found reduced brain gray matter 
concentration in left gyrus rectus, bilateral superior frontal gyri, left precentral gyrus, 
bilateral frontomarginal gyri, bilateral anterior cingulated gyri, right insular gyrus, bilateral 
caudate nuclei, bilateral thalami, bilateral amygdalo hippocampi, bilateral inferior temporal 
gyri and bilateral quadrangular and biventer lobules in cerebellum. These results suggest 
that memory impairment, executive dysfunctions, cardiovascular disturbances, and 
dysregulation of autonomic and respiratory control might be related to morphological 
differences in the brain gray matter areas (Joo et al., 2009). Yaouhi et al. (2009) observed gray 
matter loss in frontal and temporo-pareieteo-occipital cortices, the thalamus, hippocampal 
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region, some basal ganglia and cerebellar regions mainly in the right hemisphere. Brain 
morphological changes have also been found in moderate and severe OSAS patients. 
Volumes of cortical gray matter, such as right and left hippocampus and more lateral 
temporal areas were also found to be smaller in severe OSAS patients compared to controls 
(Torelli et al., 2011).  
As we have seen, hypoxia and sleep fragmentation cause cellular and molecular changes 
that lead to disruption of functional homeostasis and altered neuronal and glial viability 
within particular brain regions (Beebe & Gozal, 2002; Morrell et al., 2003), such as frontal 
lobe (Beebe et al., 2002  Fuster, 2000; Koechlin et al., 1999) and temporal cortex (Yaouhi et al., 
2009). Moreover, hypoxia and sleep deprivation modulate the expression of inflammatory 
mediators such as interleukins and tumor necrosis factor alpha (Butt et al., 2010). In 
summary, the pathophysiology of cognitive deficits in OSAS patients is multifactorial. Since 
OSAS affect multiple brain regions, brain damages may result from several etiologies such 
as hypoxemia, sleep deprivation, small vessel damages, chronic inflammation, all of which 
can result in local ischemic episodes (Matthews & Aloia, 2011). 
7. Conclusions 
In this thorough review of literature, we have shown that the majority of OSAS patients 
suffer from attentional, memory and psychomotor speed decline, while others present 
impairments in high order cognitive functions such as executive and language functions. 
CPAP treatment is not always helpful in improving cognitive functions, suggesting that 
OSAS may cause permanent damages in specific brain regions. The effects of sleep 
fragmentation, hypoxemia, low CBF, inflammation parameters and vascocerebral diseases 
on cognitive functions are intermingled and synergistic. However, these conclusions need to 
be treated with caution since most studies are not homogeneous in OSAS severity. 
Moreover, the diversity in the findings of the research studies presented  may be due to 
differences in methodology and in the types of neuropsychological tests which were used to 
assess cognitive functions. Furthermore, the treatment duration, low tolerance of treatment, 
and disease duration are not often taken into account in most studies. Therefore, more 
research is needed to elucidate the etiology of OSAS and investigate further to what extent 
sleep architecture, cerebral blood flow, gas blood, inflammation parameters, co-morbidities 
or even socioeconomic factors have a negative impact on cognitive functions in OSAS 
patients.  
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